SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001213900-21-017776
Filing Date
2021-03-25
Accepted
2021-03-25 17:04:03
Documents
63
Period of Report
2020-12-31

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT f10k2020_aditxtherap.htm 10-K 884870
2 DESCRIPTION OF SECURITIES REGISTERED UNDER SECTION 12 OF THE EXCHANGE ACT f10k2020ex4-1_aditx.htm EX-4.1 17883
3 CONSENT OF DBBMCKENNON, INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM f10k2020ex23-1_aditx.htm EX-23.1 1620
4 CERTIFICATION f10k2020ex31-1_aditx.htm EX-31.1 15589
5 CERTIFICATION f10k2020ex31-2_aditx.htm EX-31.2 15850
6 CERTIFICATION f10k2020ex31-3_aditx.htm EX-31.3 15650
7 CERTIFICATION f10k2020ex32-1_aditx.htm EX-32.1 10647
14 GRAPHIC img_001.jpg GRAPHIC 31929
15 GRAPHIC img_002.jpg GRAPHIC 42807
16 GRAPHIC img_003.jpg GRAPHIC 36800
17 GRAPHIC img_004.jpg GRAPHIC 19768
18 GRAPHIC img_005.jpg GRAPHIC 18717
19 GRAPHIC img_006.jpg GRAPHIC 18319
20 GRAPHIC img_007.jpg GRAPHIC 34488
  Complete submission text file 0001213900-21-017776.txt   4030333

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE FILE adtx-20201231.xml EX-101.INS 406612
9 XBRL SCHEMA FILE adtx-20201231.xsd EX-101.SCH 50278
10 XBRL CALCULATION FILE adtx-20201231_cal.xml EX-101.CAL 32192
11 XBRL DEFINITION FILE adtx-20201231_def.xml EX-101.DEF 225373
12 XBRL LABEL FILE adtx-20201231_lab.xml EX-101.LAB 453915
13 XBRL PRESENTATION FILE adtx-20201231_pre.xml EX-101.PRE 236375
Mailing Address 2569 WYANDOTTE, ST. SUITE 101 MOUNTAIN CA 94043
Business Address 2569 WYANDOTTE, ST. SUITE 101 MOUNTAIN CA 94043 909-488-0844
Aditx Therapeutics, Inc. (Filer) CIK: 0001726711 (see all company filings)

IRS No.: 823204328 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-39336 | Film No.: 21773175
SIC: 2834 Pharmaceutical Preparations